Furthermore, expression of MAdCAM-1 in other mucosal tissues as well as in joints, eyes, skin and liver (46–48) make it a potential treatment option for extraintestinal manifestations of IBD and other inflammatory diseases (49). Here, MADCAM1 is linked to inflammatory bowel disease.